• From Foundation to Platform
  • Part 3: Shifting from “biotech as research” to “biotech as infrastructure”
  • Part 2: “AI for biology” actually needs “Standardized biology for AI”
From Foundation to Platform
Part 3: Shifting from “biotech as research” to “biotech as infrastructure”
Part 2: “AI for biology” actually needs “Standardized biology for AI”
From Foundation to Platform
Bio-OS™ and the Emergence of Biological Operating Infrastructure
Part 3: Shifting from “biotech as research” to “biotech as infrastructure”
To: NSCEB leadership; Senator Todd Young; Michelle Rozo, PhD; Rep. Chrissy Houlahan; Rep. Ro Khanna; Rep. Deborah Ross; Rep. Stephanie Bice; Rep. Jim Baird; Rep. David Rouzer; Rep. Pete Sessions; Rep. April McClain Delaney; Rep. Don Davis, and the federal and state imple...
Part 2: “AI for biology” actually needs “Standardized biology for AI”
To: Michael Kratsios, Chris Wright, Dario Gil, Ethan Klein, Emil Michael, Stephen Winchell 
Hydrogels as Infrastructure
A Materials Maturity Framework for the Next Era of Biology
Charter a National Interoperability and Biometrology Standards Track

To: Michelle Rozo, PhD; Senator Todd Young; NSCEB; the National Biotechnology Coordination Office (NBCO) and NIST
The Amnion Foundation, Inc partners with Ronawk, Inc to Advance Perinatal Stem Cell Research

Overland Park, KS and Winston-Salem, NC — November 12, 2025 — Ronawk, the developer of the biological operating system (Bio-OS™), announced a strategic partnership agreement with the Amnion Foundation, a pioneering nonprofit dedicated to advancing research in perinatal s...
Cellipont Bioservices and Ronawk Partner to Advance Scalable Expansion of High-Quality Mesenchymal Stem Cells and Biologics

The WOODLANDS, Texas, and OVERLAND PARK, Kansas — November 19, 2025/ Cision / – Cellipont Bioservices, a leading cell therapy Contract Development and ManufacturingOrganization (CDMO), today announced a strategic collaboration with Ronawk, developer of theBio-OS™ biologi...
Micro-gRx, Ronawk, and University of Florida Collaborate on Translational Research in Advanced Tissue Engineering Aboard the International Space Station

*Orlando, FL* – Micro-gRx, in partnership with Ronawk and the University of Florida, is excited to announce a collaboration on an innovative tissue engineering experiment. The study will advance in-space three-dimensional cell culture processes and study the effects of m...
Ronawk Joins the Wake Forest School of Medicine Institute for Regenerative Medicine and ReMDO Endeavors and Enters the Test Bed to Accelerate Next-Gen Therapies

Ronawk, the leader in Advanced Tissue Mimetic Technologies, and the creator of the Bio-Block Universe®, announced today it is joining the RegenMed Development Organization (ReMDO) RegeneratOR Test Bed in Winston-Salem, North Carolina.  Ronawk’s Bio-Blocks™ are a 3D print...
Press Kit

Ronawk's Bio-OS cultivates cells in a scalable environment that mimic the body.

At Ronawk, we are building a biological operating system (Bio-OS™) that acts as a compass for mammalian biology. Legacy biomanufacturing technologies were designed for microbes like yeast or bacteria. They exhaust mammalian cells, making production inefficient and cost prohibitive. Bio-OS was designed from the ground up for mammalian cells, which are the very cells needed for therapies, biologics, and regenerative medicine. 

How Bio-OS Works
* Clients define the outputs they need: stem cells, exosomes, or tissue components.
* Ronawk aligns key biological variables using our proprietary substrates and protocols.
* We then tune and customize outputs to customer specifications.
* The result is a standardized, enterprise-ready, and capital-efficient bio-manufacturing solution.

Instead of burning cells out, Ronawk’s Bio-OS cultivates them in environments that mimic the body. This yields healthier, more potent outputs at a fraction of the cost and footprint of current systems. 

Want to learn more?
Visit ronawk.com or contact us at info@ronawk.com.